David D. Ho

89.4k total citations · 28 hit papers
350 papers, 54.2k citations indexed

About

David D. Ho is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, David D. Ho has authored 350 papers receiving a total of 54.2k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Virology, 209 papers in Infectious Diseases and 118 papers in Immunology. Recurrent topics in David D. Ho's work include HIV Research and Treatment (211 papers), HIV/AIDS drug development and treatment (111 papers) and Immune Cell Function and Interaction (79 papers). David D. Ho is often cited by papers focused on HIV Research and Treatment (211 papers), HIV/AIDS drug development and treatment (111 papers) and Immune Cell Function and Interaction (79 papers). David D. Ho collaborates with scholars based in United States, China and Hong Kong. David D. Ho's co-authors include Martin Markowitz, Alan S. Perelson, Avidan U. Neumann, John M. Leonard, Linqi Zhang, Tarsem Moudgil, Yunzhen Cao, John P. Moore, Arlene Hurley and Yaoxing Huang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David D. Ho

347 papers receiving 52.5k citations

Hit Papers

Rapid turnover of plasma virions and CD4 lymphocytes in H... 1985 2026 1998 2012 1995 1996 1997 1994 1997 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
    1995 3.3k citations David D. Ho, Alan S. Perelson et al. Nature profile →
  2. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
    1996 2.6k citations Alan S. Perelson, Martin Markowitz et al. Science profile →
  3. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
    1997 2.4k citations Martin Markowitz, David D. Ho et al. Science profile →
  4. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
    1994 2.0k citations Richard A. Koup, Jeffrey T. Safrit et al. profile →
  5. Decay characteristics of HIV-1-infected compartments during combination therapy
    1997 1.5k citations Alan S. Perelson, Martin Markowitz et al. Nature profile →
  6. Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
    1998 1.2k citations Yunzhen Cao, Martin Markowitz et al. Science profile →
  7. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
    1999 1.1k citations Sharon R. Lewin, Agegnehu Gettie et al. profile →
  8. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
    1996 1.1k citations Yaoxing Huang, Steven M. Wolinsky et al. Nature Medicine profile →
  9. Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
    1993 1.0k citations Hongmei Mo, Yunzhen Cao et al. Science profile →
  10. Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
    1994 938 citations Dennis R. Burton, Yunzhen Cao et al. Science profile →
  11. Identification of microRNAs of the herpesvirus family
    2005 896 citations David D. Ho et al. profile →
  12. Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
    1989 889 citations David D. Ho, Tarsem Moudgil et al. New England Journal of Medicine profile →
  13. Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome
    1985 836 citations David D. Ho, Martin Hirsch et al. New England Journal of Medicine profile →
  14. Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection
    1995 796 citations Yunzhen Cao, Linqi Zhang et al. New England Journal of Medicine profile →
  15. Recognition of bacterial glycosphingolipids by natural killer T cells
    2005 742 citations David D. Ho et al. Nature profile →
  16. Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
    1999 691 citations Linqi Zhang, Sharon R. Lewin et al. New England Journal of Medicine profile →
  17. Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection
    1991 653 citations Tarsem Moudgil, David D. Ho et al. New England Journal of Medicine profile →
  18. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
    1996 601 citations Akhteruzzaman Molla, Marina Korneyeva et al. Nature Medicine profile →
  19. Infection of monocyte/macrophages by human T lymphotropic virus type III.
    1986 582 citations David D. Ho, Martin Hirsch et al. profile →
  20. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
    1993 543 citations John P. Moore, David D. Ho et al. profile →
  21. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
    2022 495 citations Qian Wang, Sho Iketani et al. profile →
  22. Antibody evasion properties of SARS-CoV-2 Omicron sublineages
    2022 478 citations Sho Iketani, Lihong Liu et al. Nature profile →
  23. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
    2022 433 citations Qian Wang, Yicheng Guo et al. Nature profile →
  24. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
    2021 390 citations Pengfei Wang, Manoj S. Nair et al. profile →
  25. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
    2022 260 citations Sho Iketani, Hiroshi Mohri et al. Nature profile →
  26. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
    2023 100 citations Qian Wang, Yicheng Guo et al. Nature profile →
  27. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
    2023 85 citations Dennis R. Burton, Lihong Liu et al. profile →
  28. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
    2024 80 citations Qian Wang, Yicheng Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. Ho United States 115 38.3k 27.4k 19.2k 10.9k 7.7k 350 54.2k
Beatrice H. Hahn United States 105 29.9k 0.8× 18.1k 0.7× 15.2k 0.8× 10.2k 0.9× 9.0k 1.2× 416 44.7k
Douglas D. Richman United States 113 39.2k 1.0× 37.2k 1.4× 10.2k 0.5× 13.0k 1.2× 7.1k 0.9× 509 55.6k
Bruce D. Walker United States 120 32.6k 0.9× 15.3k 0.6× 27.6k 1.4× 13.0k 1.2× 9.6k 1.2× 583 52.4k
George M. Shaw United States 91 25.1k 0.7× 14.2k 0.5× 11.9k 0.6× 7.7k 0.7× 5.4k 0.7× 236 32.1k
Richard A. Koup United States 102 22.9k 0.6× 13.9k 0.5× 24.4k 1.3× 9.4k 0.9× 6.4k 0.8× 309 42.6k
Robert C. Gallo United States 128 29.3k 0.8× 18.5k 0.7× 35.1k 1.8× 13.3k 1.2× 18.7k 2.4× 700 76.9k
Joseph Sodroski United States 118 42.6k 1.1× 19.0k 0.7× 27.5k 1.4× 9.9k 0.9× 15.8k 2.0× 446 56.3k
Robert F. Siliciano United States 90 26.2k 0.7× 17.2k 0.6× 11.6k 0.6× 5.6k 0.5× 5.6k 0.7× 308 31.5k
Daniel C. Douek United States 104 19.1k 0.5× 11.1k 0.4× 26.6k 1.4× 9.5k 0.9× 6.2k 0.8× 338 44.9k
John P. Moore United States 110 30.2k 0.8× 14.1k 0.5× 16.8k 0.9× 6.0k 0.6× 10.0k 1.3× 384 37.5k

Countries citing papers authored by David D. Ho

Since Specialization
Citations

This map shows the geographic impact of David D. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Ho more than expected).

Fields of papers citing papers by David D. Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Ho. The network helps show where David D. Ho may publish in the future.

Co-authorship network of co-authors of David D. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Ho. A scholar is included among the top collaborators of David D. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Ho. David D. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qian, Yicheng Guo, Ian A. Mellis, et al.. (2025). Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC. Cell Reports. 44(4). 115543–115543. 12 indexed citations
2.
Morano, Nicholas C., Yicheng Guo, Zhiteng Li, et al.. (2025). Structure of a zoonotic H5N1 hemagglutinin reveals a receptor-binding site occupied by an auto-glycan. Structure. 33(2). 228–233.e3. 1 indexed citations
3.
Liu, Hengrui, Arie Zask, F. Forouhar, et al.. (2025). Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nature Communications. 16(1). 152–152. 1 indexed citations
4.
Morano, Nicholas C., Haijuan Du, Kwok‐Yung Yuen, et al.. (2024). Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head. Nature Communications. 15(1). 4505–4505. 4 indexed citations
5.
Wang, Lin‐Fa, Sharon R. Lewin, Nanshan Zhong, et al.. (2024). Pandemic research: the need for a paradigm shift. The Lancet Microbe. 6(4). 101048–101048. 2 indexed citations
6.
Nair, Manoj S., Ruy M. Ribeiro, Maple Wang, et al.. (2023). Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost. iScience. 26(4). 106345–106345. 3 indexed citations
7.
Wang, Qian, Yicheng Guo, Hiroshi Mohri, et al.. (2023). Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2. Emerging Microbes & Infections. 12(1). 2210237–2210237. 2 indexed citations
8.
Iketani, Sho, Lihong Liu, Yicheng Guo, et al.. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 604(7906). 553–556. 478 indexed citations breakdown →
9.
Iketani, Sho, Hiroshi Mohri, Bruce Culbertson, et al.. (2022). Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature. 613(7944). 558–564. 260 indexed citations breakdown →
10.
Wagh, Kshitij, Michael S. Seaman, Dan H. Barouch, et al.. (2018). Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathogens. 14(3). e1006860–e1006860. 57 indexed citations
11.
Andrews, Chasity D., William Spreen, Hiroshi Mohri, et al.. (2014). Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus. Science. 343(6175). 1151–1154. 120 indexed citations
12.
Spira, Alexander I., Preston A. Marx, Bruce K. Patterson, et al.. (1998). Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques. AIDS Research and Human Retroviruses. 14. 15 indexed citations
13.
Molla, Akhteruzzaman, Marina Korneyeva, Qing Gao, et al.. (1996). Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine. 2(7). 760–766. 601 indexed citations breakdown →
14.
Cao, Yunzhen, et al.. (1995). Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. New England Journal of Medicine. 332(4). 201–208. 796 indexed citations breakdown →
15.
Connor, Ruth I. & David D. Ho. (1994). Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 10(4). 321–323. 27 indexed citations
16.
Moore, John P., Hironori Yoshiyama, David D. Ho, James E. Robinson, & Joseph Sodroski. (1993). Antigenic Variation in gp120s from Molecular Clones of HIV-1 LAI. AIDS Research and Human Retroviruses. 9(12). 1185–1193. 32 indexed citations
17.
18.
Connor, Ruth I., et al.. (1993). Biological Cloning of Functionally Diverse Quasispecies of HIV-1. AIDS Research and Human Retroviruses. 9(6). 541–546. 25 indexed citations
19.
Ho, David D., et al.. (1992). Discontinuous Epitopes on gp120 Important in HIV-1 Neutralization. AIDS Research and Human Retroviruses. 8(8). 1337–1339. 11 indexed citations
20.
Meyer, Roxanne, Tarsem Moudgil, Roger Detels, et al.. (1990). Seroprevalence of Human T Cell Leukemia Viruses in Selected Populations of Homosexual Men. The Journal of Infectious Diseases. 162(6). 1370–1372. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatrice H. Hahn Breakdown of academic impact, for papers by Douglas D. Richman Breakdown of academic impact, for papers by Bruce D. Walker Breakdown of academic impact, for papers by George M. Shaw Breakdown of academic impact, for papers by Richard A. Koup Breakdown of academic impact, for papers by Robert C. Gallo Breakdown of academic impact, for papers by Joseph Sodroski Breakdown of academic impact, for papers by Robert F. Siliciano Breakdown of academic impact, for papers by Daniel C. Douek Breakdown of academic impact, for papers by John P. Moore
Rankless by CCL
2026